Ranjan Sengupta
About Ranjan Sengupta
Ranjan Sengupta is a scientist at the Structural Cell Biology Section of the National Institutes of Health, specializing in the study of viral and bacterial infections using advanced microscopy techniques. He holds a Master of Science in Virology from UC Riverside and a Ph.D. in Virology and Cell Biology from Purdue University.
Work at National Institutes of Health
Ranjan Sengupta serves as a Scientist in the Structural Cell Biology Section at the National Institutes of Health (NIH), specifically within the National Institute on Deafness and Other Communication Disorders (NIDCD). He has been in this role since 2021, contributing to the understanding of cell biology related to viral and bacterial infections. His work involves utilizing advanced microscopy techniques to investigate the ultrastructural and functional consequences of pathogenic infections.
Education and Expertise
Ranjan Sengupta holds a Master of Science (MS) in Virology from the University of California, Riverside. He also earned a Ph.D. in Virology and Cell Biology from Purdue University, where he studied from 2004 to 2011. His educational background equips him with a strong foundation in virology and cell biology, enabling him to conduct significant research in these fields.
Background
Prior to his current position at NIH, Ranjan Sengupta worked at Purdue University as a Postdoctoral Research Fellow from 2012 to 2018, followed by a role as an Assistant Research Scientist from 2018 to 2020. His experiences at Purdue University provided him with extensive research experience in virology and cell biology, focusing on the interactions between viral and cellular proteins.
Research Focus and Techniques
Ranjan Sengupta's research primarily focuses on the subcellular localization and trafficking of viral and cellular proteins that influence host cell membranes and cellular pathways. He employs 3D electron microscopy and light microscopy to study viral and bacterial infections, including Ebola, SARS-CoV-2, flaviviruses, and alphaviruses. His aim is to develop integrative imaging methods and tools that enhance the capabilities of traditional cell biologists and virologists.